あなたはまだ TradeKey.com のメンバーではないようです。 今すぐサインアップして、世界中で700万を超える輸入業者および輸出業者と接続します。
今すぐ加入、無料 |
BOOK A CALL
Book Call On Your Favorite Time

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us
TRV-130.HCl  cas no 1401031-39-7 API Bioactive small molecules  Pharmarceutical products

TRV-130.HCl cas no 1401031-39-7 API Bioactive small molecules Pharmarceutical products

FOB Price

Get Latest Price

|

Minimum Order

Place of Origin:

-

Price for Minimum Order:

-

Minimum Order Quantity:

-

Packaging Detail:

50mg 100mg 500mg 1g 5g 10g

Delivery Time:

-

Supplying Ability:

-

Payment Type:

-

今すぐお問い合わせください
無料会員

連絡先担当者 Winne

Wuhan, Other

今すぐお問い合わせください

Description

Chemical Information

Product Name TRV**0(Oliceridine)
Iupac Chemical Name [(*-Methoxythiophen**-yl)methyl]({*-[(9R)**-(pyridin**-yl)**-oxaspiro-[4.5]decan**-yl]ethyl})amine 
Synonyms TRV***0,TRV**0,TRV **0;Oliceridine 
Molecular Formula C*2H*1ClN2O2S 
Molecular Weight **3.*1 
Smile
InChiKey DMNOVGJWPASQDL-OAQYLSRUSA-N
InChi InChI=1S/C*2H*0N2O2S/c*****************9(*8)*************1(****************0)**********2(****1)*********2/h2,**7,*2,*5,*3H,**4,***1,****4,****7H2,1H3/t**-/m1/s1
Cas ***********7
Technical Data
Appearance white solid 
Purity *8% 
Solubility 5mg/ml in DMSO 
Storage 3 years **0ºCpowder 
Shipping Condition Shipped under ambient temperature. 
Quality control  
Description

TRV **0 Hcl is a novel -opioid receptor (MOR) G protein-biased ligand; elicits robust G protein signaling(pEC*0=8.1), with potency and efficacy similar to morphine, but with far less -arrestin recruitment and receptor internalization.

The drug, recently granted FDA breakthrough therapy designation, has entered phase III clinical development as a treatment for acute pain

Send a direct inquiry to this supplier

To:

Winne < Wuhan Sun-shine Bio-technology Corporation Limited >

私は知りたい: